Laidlaw is an internationally-recognized firm that focuses primarily on investment banking. Recently the company has been under fire from Relmada, which is a therapeutics corporation that deals primarily with developing novel therapies for the treatment of chronic pain as well as a host of other conditions that customers maybe ailing from. LaidLaw has represented Relmada Therapeutics Incorporated for a certain number of years, beginning in 2011. Relmada is currently seeking monetary damages arising from fees and costs incurred in relation to monetary loss, as well as other breaches of contract. As a result of this Relmada has sought a restraining order from the Nevada court against LaidLaw and its principles, being called to compensate Relmada for damages suffered as a result. This restraining order as well as other lawsuits filed against LaidLaw was done in order for Relmada to protect itself from further problems with the company in the near future.
This news is fairly startling as LaidLaw is an internationally recognized and highly respectable company that has been in business for over 170 years. The corporation has protected domestic and international trading and banking in a multitude of different countries across the globe. This also includes damage control for companies so that they know which decisions to make it and what times. Asset location has been a big deal through Laidlaw investment company and they promote the ability to spread investment opportunities across the board, not focusing on one area too much.
The situation with Relmada is daunting and confusing as LaidLaw Investment Banking is such a high-ranking corporation within the investment business world. Personally I don’t think the company should be blamed for any of this and that Relmada needs to take a second look at what’s going on with your corporation before making any final decisions.